University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 1 of 24
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
NCT06373289
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
NCT07135453
Empowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City
NCT07556354
Adapting Enhanced Recovery Programs for Low Health Literacy Patients
NCT06356558
Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction
NCT07224529
Process-Based Approach Case Series For Anxiety Problems
NCT07352592
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
NCT04861077
Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)
NCT07102043
Use of Tinted Contact Lenses for Concussion-Related Light Sensitivity
NCT07223086
Boosting Olfactory and Sensory Training Study (BOOST)
NCT07221123
Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial
NCT07161726
Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
NCT07292584
Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
NCT06902714
Folic Acid Salt Study (FISFA Zambia)
NCT06734611
Pilot Assessment of Continuous Glucose Monitor for Post-meal Glucose Responses to Herbs and Spices.
NCT07254624
VENTURI (VENTilation Using Respiratory Imaging)
NCT07282886
To Compare Post-Extraction Use of a Novel Ethylenediaminetetraacetic Acid (EDTA) Post-operative Mouth Rinse and Daily Use EDTA Mouth Rinse and Standard 0.12% Chlorhexidine (CHX) Post-operative Mouth Rinse and Daily Use Essential Oil (EO) Mouth Rinse.
NCT07191262
Development of an Inclusive Adaptive Treatment Strategy for Weight Loss in People With Prediabetes Using a Sequential Multiple Assignment Randomized Trial
NCT06976307
Brain Uptrain to Improve Learning and Development
NCT06638801
Early Time-Restricted Eating in Older Adults With Hypertension
NCT07135505
PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking
NCT07231640
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
NCT07025109
Early Life Exposures Among Children With Sickle Cell Disease
NCT05377372
Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access
NCT07208071
HIV, Equity, and Addiction Training (HEAT) Program
NCT06370481
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
NCT07250854
Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sagittal Split: A Split-Mouth Study
NCT07104656
FELLAShip to Better Health
NCT07220213
Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
NCT06785064
The Effects of Exogenous Ketones on Cognitive Function
NCT07051655
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
NCT06902077
Inspire HER: Inspiring the Heart and Emotions for Radical Health
NCT06966258
Leading Healthy Eating and Activity Promotion Program
NCT06868524
The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy
NCT06599697
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
NCT06629649
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
NCT07197515
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
NCT06420531
Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
NCT07557706
Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization
NCT06565390
The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD)
NCT06832007
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
NCT07135427
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
NCT06188741
The ARISE Study - Use of Vertical Positioning
NCT07025421
Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
NCT06911723
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
NCT06294574
The Effect of Spinal Cord Stimulators on Restless Leg Syndrome
NCT07179406
Ventilator Pressure and Optimization of Compliance and Hemodynamics
NCT06512935
Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
NCT06962488
Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity
NCT06736028
Acceptance and Commitment Therapy for Religious OCD
NCT06647589
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets.Report a data error.